These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 7727820)

  • 21. The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial: rationale, design, results, clinical implications and lessons for future trials.
    Wilkoff BL;
    Card Electrophysiol Rev; 2003 Dec; 7(4):468-72. PubMed ID: 15071277
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The next treatment option: using ventricular assist devices for heart failure.
    Stahovich M; Chillcott S; Dembitsky WP
    Crit Care Nurs Q; 2007; 30(4):337-46. PubMed ID: 17873570
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A taxonomy for disease management: a scientific statement from the American Heart Association Disease Management Taxonomy Writing Group.
    Krumholz HM; Currie PM; Riegel B; Phillips CO; Peterson ED; Smith R; Yancy CW; Faxon DP;
    Circulation; 2006 Sep; 114(13):1432-45. PubMed ID: 16952985
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Development of measure for disease-specific quality of life in patients with chronic heart failure].
    Tamura M; Omiya K; Yamada S; Oka K; Suzuki N; Osada N; Miyake F
    J Cardiol; 2003 Oct; 42(4):155-64. PubMed ID: 14598717
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quality of life in patients with chronic heart failure.
    Grady KL
    Crit Care Nurs Clin North Am; 1993 Dec; 5(4):661-70. PubMed ID: 8297555
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Currently available ventricular-assist devices: capabilities, limitations and future perspectives.
    Ohuchi K; Takatani S
    Expert Rev Med Devices; 2006 Mar; 3(2):195-205. PubMed ID: 16515386
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Left ventricular assist device as destination for patients undergoing intravenous inotropic therapy: a subset analysis from REMATCH (Randomized Evaluation of Mechanical Assistance in Treatment of Chronic Heart Failure).
    Stevenson LW; Miller LW; Desvigne-Nickens P; Ascheim DD; Parides MK; Renlund DG; Oren RM; Krueger SK; Costanzo MR; Wann LS; Levitan RG; Mancini D;
    Circulation; 2004 Aug; 110(8):975-81. PubMed ID: 15313942
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The Kansas City Cardiomyopathy Questionnaire (KCCQ) -- a new disease-specific quality of life measure for patients with chronic heart failure].
    Faller H; Steinbüchel T; Schowalter M; Spertus JA; Störk S; Angermann CE
    Psychother Psychosom Med Psychol; 2005; 55(3-4):200-8. PubMed ID: 15800814
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Health-related quality-of-life studies of the National Cancer Institute of Canada Clinical Trials Group.
    Osoba D; Dancey J; Zee B; Myles J; Pater J
    J Natl Cancer Inst Monogr; 1996; (20):107-11. PubMed ID: 8750480
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quality of life and the heart: evaluation of therapeutic alternatives.
    Bulpitt CJ; Fletcher AE
    Br J Clin Pract Suppl; 1994 May; 73():18-22. PubMed ID: 8031703
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of a multidimensional measure for recurrent abdominal pain in children: population-based studies in three settings.
    Malaty HM; Abudayyeh S; O'Malley KJ; Wilsey MJ; Fraley K; Gilger MA; Hollier D; Graham DY; Rabeneck L
    Pediatrics; 2005 Feb; 115(2):e210-5. PubMed ID: 15687428
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
    Klassen AF; Miller A; Fine S
    Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Technology eases living with heart failure. New implantable devices, stem cell therapy, and monitoring techniques may improve length and quality of life.
    Health News; 2005 Feb; 11(2):7-8. PubMed ID: 15732151
    [No Abstract]   [Full Text] [Related]  

  • 34. Choices: a study of preferences for end-of-life treatments in patients with advanced heart failure.
    MacIver J; Rao V; Delgado DH; Desai N; Ivanov J; Abbey S; Ross HJ
    J Heart Lung Transplant; 2008 Sep; 27(9):1002-7. PubMed ID: 18765193
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The NCI All Ireland Cancer Conference.
    Johnston PG; Daly PA; Liu E
    Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment of patient-reported outcomes in clinical trials: the example of health-related quality of life.
    Wiklund I
    Fundam Clin Pharmacol; 2004 Jun; 18(3):351-63. PubMed ID: 15147288
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Controlled randomized clinical trials].
    Jaillon P
    Bull Acad Natl Med; 2007; 191(4-5):739-56; discussion 756-8. PubMed ID: 18225427
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Symptomatic relief: left ventricular assist devices versus resynchronization therapy.
    Delgado RM; Radovancevic B
    Heart Fail Clin; 2007 Jul; 3(3):259-65. PubMed ID: 17723934
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Measuring quality of life today: methodological aspects.
    Cella DF; Tulsky DS
    Oncology (Williston Park); 1990 May; 4(5):29-38; discussion 69. PubMed ID: 2143408
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Answering important questions reliably--GISSI Heart Failure, a factorially designed trial with composite (co)primary outcome measures.
    Freemantle N; Calvert M
    Eur J Heart Fail; 2004 Aug; 6(5):531-3. PubMed ID: 15301997
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.